APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 29 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,611,000 | – | 1,500,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 54,825,000 | $92,483,000 | 1.83% |
| Opti Capital Management, LP | 5,000,000 | $8,414,000 | 0.94% |
| Castle Creek Arbitrage, LLC | 8,984,000 | $15,089,000 | 0.92% |
| CSS LLC/IL | 5,919,000 | $9,944,000 | 0.38% |
| LMR Partners LLP | 8,640,000 | $14,556,000 | 0.23% |
| MACKAY SHIELDS LLC | 18,878,000 | $31,802,000 | 0.22% |
| Shaolin Capital Management LLC | 1,693,000 | $2,857,000 | 0.20% |
| SSI INVESTMENT MANAGEMENT LLC | 1,500,000 | $2,516,000 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,502,000 | $20,991,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,370,000 | $3,983,000 | 0.10% |